[Financial Performance]: ALZ.ST's revenue, profit margins, and earnings per share directly influence investor confidence. Strong financial results typically lead to increased demand and a higher stock price.

[Industry Trends]: The overall health and growth prospects of the Alzheimer's research and pharmaceutical industry play a significant role. Positive developments in the field can boost investor sentiment and drive up ALZ.ST's value.

[Clinical Trial Results]: As a company focused on Alzheimer's research, the outcomes of its clinical trials are crucial. Positive results often lead to a surge in stock price, while negative or inconclusive results can have the opposite effect.

[Regulatory Approvals]: The success of ALZ.ST depends on obtaining regulatory approval for its potential treatments. Approval by agencies like the FDA can significantly increase the stock price.

[Competitor Activity]: Actions taken by competitors in the Alzheimer's space, such as drug approvals or acquisitions, can impact ALZ.ST's valuation. Increased competition may lead to price decreases.

[Market Sentiment]: General market conditions and investor sentiment toward the biotechnology sector can influence ALZ.ST's stock price. A bullish market usually supports higher valuations.

[Economic Conditions]: Macroeconomic factors, such as interest rates, inflation, and economic growth, can indirectly affect ALZ.ST by influencing investor risk appetite and funding availability.

[Company News]: Announcements of partnerships, collaborations, or significant milestones can also influence the stock price.